Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Emphysema Treatment Market: By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Others; By Types of Diseases; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments
Global Emphysema Treatment Market Outlook
The global emphysema treatment market is being aided by the growth of the overall chronic obstructive pulmonary disease treatment market. The global chronic obstructive pulmonary disease treatment market is expected to grow at a CAGR of 4.8% in the forecast period of 2023-2028 to reach a value of approximately USD 24.7 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Significantly Contribute to the Emphysema Treatment Industry
North America accounts for a significant share in the industry owing to the growing cases of chronic obstructive pulmonary diseases (COPD) in the region and the availability of improved healthcare facilities. According to estimates, COPD is one of the leading causes of deaths in the United States. North America is followed by Europe. The availability of diagnostic services for respiratory illness is propelling the industry growth in the European region. Meanwhile, the growing presence of smoking population and the rising pollution levels in the Asia Pacific are expected to create new opportunities for the market expansion in the forecast period.
Emphysema Treatment: Market Segmentation
Emphysema, which is a type of chronic obstructive pulmonary disease (COPD), is a lung condition that leads to the shortness of breath due to the damage caused to the air sacs (alveoli) in the lungs. The patient suffering from emphysema can be treated by improving shortness of breath.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By treatment, the market is divided into:
- Smoking Cessation
- Bronchodilators
- Steroids
- Leukotriene Modifiers
- Supplemental Oxygen
- Antibiotics
- Gene Therapy
- Surgery Transplant
- Others
Based on types of diseases, the industry can be segmented into:
- Shortness of Breath
- Chronic Cough
- Chronic Mucus Production
- Chest Tightness
- Wheezing
- Fatigue
- Lowered Immunity
- Weight Loss
- Thin and Very Pink Skin
- Others
Based on end use, the industry can be categorised into:
- Hospital
- Clinics
- Surgical Centre
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increase in the Number of Smokers Globally to Augment the Emphysema Treatment Industry Growth
The increase in the number of tobacco smokers is driving the growth of the emphysema treatment industry. The growing prevalence of chronic lung disorders and the availability of advanced diagnostic facilities are resulting in the increased demand for treatment for emphysema. Other factors such as the sedentary lifestyle, growing urbanisation and industrialisation, and rising pollution levels are further propelling the industry growth. Over the forecast period, the growing R&D activities and the advancements in the medical sector are expected to drive the growth of the global emphysema treatment industry.
Key Industry Players in the Global Emphysema Treatment Market
The report gives a detailed analysis of the following key players in the global emphysema treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Pulmonx Corporation
- Kamada Limited
- Pfizer Inc.
- Uptake Medical Technology Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Treatment, Types of Diseases, End Use, Region |
| Breakup by Treatment | Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Others |
| Breakup by Types of Diseases | Shortness of Breath, Chronic Cough, Chronic Mucus Production, Chest Tightness, Wheezing, Fatigue, Lowered Immunity, Weight Loss, Thin and Very Pink Skin, Others |
| Breakup by End Use | Hospitals, Clinics, Surgical Centres, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Pulmonx Corporation, Kamada Limited, Pfizer Inc., Uptake Medical Technology Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Emphysema Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Emphysema Treatment Historical Market (2018-2022)
8.3 Global Emphysema Treatment Market Forecast (2023-2028)
8.4 Global Emphysema Treatment Market by Treatment
8.4.1 Smoking Cessation
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Bronchodilators
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Steroids
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Leukotriene Modifiers
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Supplemental Oxygen
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2022)
8.4.5.3 Forecast Trend (2023-2028)
8.4.6 Antibiotics
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2018-2022)
8.4.6.3 Forecast Trend (2023-2028)
8.4.7 Gene Therapy
8.4.7.1 Market Share
8.4.7.2 Historical Trend (2018-2022)
8.4.7.3 Forecast Trend (2023-2028)
8.4.8 Surgery Transplant
8.4.8.1 Market Share
8.4.8.2 Historical Trend (2018-2022)
8.4.8.3 Forecast Trend (2023-2028)
8.4.9 Others
8.5 Global Emphysema Treatment Market by Types of Diseases
8.5.1 Shortness of Breath
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Chronic Cough
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Chronic Mucus Production
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Chest Tightness
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Wheezing
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Fatigue
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2018-2022)
8.5.6.3 Forecast Trend (2023-2028)
8.5.7 Lowered Immunity
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2018-2022)
8.5.7.3 Forecast Trend (2023-2028)
8.5.8 Weight Loss
8.5.8.1 Market Share
8.5.8.2 Historical Trend (2018-2022)
8.5.8.3 Forecast Trend (2023-2028)
8.5.9 Thin and Very Pink Skin
8.5.9.1 Market Share
8.5.9.2 Historical Trend (2018-2022)
8.5.9.3 Forecast Trend (2023-2028)
8.5.10 Others
8.6 Global Emphysema Treatment Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Surgical Centres
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Others
8.7 Global Emphysema Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Pulmonx Corporation
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Kamada Limited
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Pfizer Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Uptake Medical Technology Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Emphysema Treatment Market: Key Industry Highlights, 2018 and 2028
2. Global Emphysema Treatment Historical Market: Breakup by Treatment (USD Billion), 2018-2022
3. Global Emphysema Treatment Market Forecast: Breakup by Treatment (USD Billion), 2023-2028
4. Global Emphysema Treatment Historical Market: Breakup by Types of Diseases (USD Billion), 2018-2022
5. Global Emphysema Treatment Market Forecast: Breakup by Types of Diseases (USD Billion), 2023-2028
6. Global Emphysema Treatment Historical Market: Breakup by End Use (USD Billion), 2018-2022
7. Global Emphysema Treatment Market Forecast: Breakup by End Use (USD Billion), 2023-2028
8. Global Emphysema Treatment Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Emphysema Treatment Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Emphysema Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Emphysema Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Emphysema Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Emphysema Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Emphysema Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Emphysema Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Emphysema Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Emphysema Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Emphysema Treatment Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Emphysema Treatment Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Emphysema Treatment Market Structure
Key Questions Answered in the Report
The global emphysema treatment market is being aided by the growing chronic obstructive pulmonary disease treatment market, which is projected to grow at a CAGR of 4.8% between 2021 and 2026.
The chronic obstructive pulmonary disease treatment market is estimated to reach about USD 24.7 billion by 2026 and is further expected to aid the growth of the emphysema treatment industry.
The major drivers of the industry, such as the rising pollution levels, increasing smoking population, developing healthcare facilities, increasing prevalence of chronic obstructive pulmonary diseases, and escalating disposable incomes, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing investments in R&D activities and the advancing medical sector.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading treatment types in the market are smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, and surgery transplant, among others.
The major types of diseases considered in the market are shortness of breath, chronic cough, chronic mucus production, chest tightness, wheezing, fatigue, lowered immunity, weight loss, and thin and very pink skin, among others.
The significant end use sectors in the industry are hospital, clinics, and surgical centre, among others.
The major players in the industry are Pulmonx Corporation, Kamada Limited, Pfizer Inc., and Uptake Medical Technology Inc., among others.
Analyst Review
The global emphysema treatment market is being driven by the rising prevalence of chronic obstructive pulmonary disease. Aided by the rising R&D activities, the chronic obstructive pulmonary disease market is expected to witness a healthy growth in the forecast period of 2023-2028, growing at a CAGR of 4.8%. The chronic obstructive pulmonary disease market is projected to reach USD 24.7 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on treatment, the market is segmented into smoking cessation, bronchodilators, steroids, leukotriene modifiers, supplemental oxygen, antibiotics, gene therapy, and surgery transplant, among others. On the basis of types of diseases, the industry is divided into shortness of breath, chronic cough, chronic mucus production, chest tightness, wheezing, fatigue, lowered immunity, weight loss, and thin and very pink skin, among others. By end use, the industry is categorised into hospital, clinics, and surgical centre, among others. The major regional markets for emphysema treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pulmonx Corporation, Kamada Limited, Pfizer Inc., and Uptake Medical Technology Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER